Tag: life sciences
-
Industry, Univ. Labs Partner on Covid-19 Therapy
Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine.
-
DNA Bar Codes Added in Spores to Track Farm Products
Synthetic microbe spores made with unique DNA identifiers are shown to be capable of safely tracking vegetable crops from the farm to retail stores.
-
MD Anderson to Advance Laser Immunotherapy
An experimental cancer treatment that uses lasers to activate drugs that invoke the immune system is being evaluated by MD Anderson Cancer Center.
-
Start-Up Creating a Simpler, Stable Liquid Biopsy
A new company spun off from University of Oxford is developing a stable and sensitive blood test to detect multiple types of cancer in their early stages.
-
Large-Scale Antibody Screening Device in Development
A system to quickly screen for human antibodies that neutralize SARS-CoV-2 or other infectious viruses is being developed at Texas A&M University.
-
Fix Discovered for Gene Therapy Virus Delivery
Researchers in France and the U.S. discovered a bacterial enzyme that blocks immune reactions to otherwise benign viruses that deliver gene therapies.
-
Biotechs Apply Crispr Gene-Editing for Hemophilia
A treatment for the blood disease hemophilia and other inherited disorders are being developed with the gene-editing technology Crispr in a biotechnology deal.
-
Covid-19 Antibody Therapy Trial Underway
A clinical trial of neutralizing antibodies to treat Covid-19 infections began testing the therapy with hospitalized patients in New York and Los Angeles.
-
Infographic – Major Cities Far Short of Herd Immunity
The data show in major American and European cities, as well as Wuhan, China, the percentage of the population with antibodies against the coronavirus.
-
NIH Funds Light-Aided Gene Therapy for Eye Disease
A company creating a gene therapy for age-related macular degeneration activated with near-infrared rays received an NIH grant to advance its technology.